PD 113271
Code | Size | Price |
---|
TAR-T28308-5mg | 5mg | £2,135.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28308-50mg | 50mg | £4,231.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28308-100mg | 100mg | £5,934.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
PD 113,271 is an analog of the fermentation products fostriecin with antitumor activity in vitro and in vivo.
CAS:
87860-38-6
Formula:
C19H27O10P
Molecular Weight:
446.389
Purity:
0.98
SMILES:
CC(O)(C=CC1OC(=O)C=CC1O)C(CC(O)C=CC=CC=CCO)OP(O)(O)=O
References
1. Takeuchi T, Kuramochi K, Kobayashi S, Sugawara F. Total synthesis and stereochemistry of the antitumor antibiotic PD 113,271. Org Lett. 2006 Nov 9;8(23):5307-10. Erratum in: Org Lett. 2007 Mar 15;9(6):1173-4. PubMed PMID: 17078704.
2. Mamber SW, Okasinski WG, Pinter CD, Tunac JB. Antimycotic effects of the novel antitumor agents fostriecin (CI-920), PD 113,270 and PD 113,271. J Antibiot (Tokyo). 1986 Oct;39(10):1467-72. PubMed PMID: 3781915.
3. Stampwala SS, Bunge RH, Hurley TR, Willmer NE, Brankiewicz AJ, Steinman CE, Smitka TA, French JC. Novel antitumor agents CI-920, PD 113,270 and PD 113,271. II. Isolation and characterization. J Antibiot (Tokyo). 1983 Dec;36(12):1601-5. PubMed PMID: 6689324.
4. Tunac JB, Graham BD, Dobson WE. Novel antitumor agents CI-920, PD 113,270 and PD 113,271. I. Taxonomy, fermentation and biological properties. J Antibiot (Tokyo). 1983 Dec;36(12):1595-600. PubMed PMID: 6689323.